KIDS Stock Price | Orthopediatrics Corp P/E, Revenue, EPS, & Forecasts

Orthopediatrics Corp • KIDS

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Orthopediatrics Corp

Ticker

KIDS

Trading on

NASDAQ

ISIN

US68752L1008

Industry

Medical Devices

Sector

Healthcare

CEO

David R. Bailey

Headquarters

2850 Frontier Drive, Warsaw, IN, United States, 46582

Employees

562

Website

orthopediatrics.com

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Metrics

BasicAdvanced

Market cap

$456M

P/E ratio

EPS

-$1.96

Dividend Yield

0.00%

Beta

1.07

Forward P/E ratio

EBIDTA

$-12.5M

Ex dividend date

Price & volume

Market cap

$456M

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

1.27

Earnings

EPS

-$1.96

EPS estimate (current quarter)

-$0.26

EPS estimate (next quarter)

-$0.30

EBITDA

$-12.5M

Revenues (TTM)

$227M

Revenues per share (TTM)

$9.74

Technicals

Beta

1.07

52-week High

$27.60

52-week Low

$15.28

50-day moving average

$17.49

200-day moving average

$20.75

Short ratio

6.3

Short %

6.96%

Management effectiveness

ROE (TTM)

-12.67%

ROA (TTM)

-4.08%

Profit margin

-20.06%

Gross profit margin

$163M

Operating margin

-7.94%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

12.20%

Share stats

Outstanding Shares

25.1M

Float

15.5M

Insiders %

32.72%

Institutions %

71.03%

Analyst Insights & forecasts

86% Buy

14% Hold

0% Sell

Based on information from 7 analysts.

Average price target

$24.14

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.29

-$0.26

-12.97%

Q4 • 24Missed

-$0.39

-$0.44

10.34%

Q1 • 25Beat

-$0.11

-$0.29

62.07%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$61.1M

$-7.1M

-11.65%

Q2 • 25

$61.3M

$-11.8M

-19.22%

Q3 • 25

0.28%

65.51%

65.06%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$504M

$148M

29.41%

Q2 • 25

$493M

$144M

29.22%

Q3 • 25

-2.01%

-2.64%

-0.65%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-10.5M

$-3.5M

$24.8M

$-13.9M

Q2 • 25

$-0.6M

$-26.8M

$-0.3M

$-3.4M

Q3 • 25

-94.45%

657.07%

-101.14%

-75.41%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Orthopediatrics Corp share?

Orthopediatrics Corp shares are currently traded for undefined per share.

How many shares does Orthopediatrics Corp have?

Orthopediatrics Corp currently has 25.1M shares.

Does Orthopediatrics Corp pay dividends?

No, Orthopediatrics Corp doesn't pay dividends.

What is Orthopediatrics Corp 52 week high?

Orthopediatrics Corp 52 week high is $27.60.

What is Orthopediatrics Corp 52 week low?

Orthopediatrics Corp 52 week low is $15.28.

What is the 200-day moving average of Orthopediatrics Corp?

Orthopediatrics Corp 200-day moving average is $20.75.

Who is Orthopediatrics Corp CEO?

The CEO of Orthopediatrics Corp is David R. Bailey.

How many employees Orthopediatrics Corp has?

Orthopediatrics Corp has 562 employees.

What is the market cap of Orthopediatrics Corp?

The market cap of Orthopediatrics Corp is $456M.

What is the P/E of Orthopediatrics Corp?

The current P/E of Orthopediatrics Corp is null.

What is the EPS of Orthopediatrics Corp?

The EPS of Orthopediatrics Corp is -$1.96.

What is the PEG Ratio of Orthopediatrics Corp?

The PEG Ratio of Orthopediatrics Corp is null.

What do analysts say about Orthopediatrics Corp?

According to the analysts Orthopediatrics Corp is considered a buy.